Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Geron Corp. (NASDAQ: GERN) closed at $4.41 in the last session, down -2.86% from day before closing price of $4.54. In other words, the price has decreased by -$2.86 from its previous closing price. On the day, 7.58 million shares were traded. GERN stock price reached its highest trading level at $4.55 during the session, while it also had its lowest trading level at $4.39.
Ratios:
We take a closer look at GERN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.61. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on September 09, 2024, initiated with a Outperform rating and assigned the stock a target price of $7.
On April 30, 2024, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $4.50.
On April 29, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $10.TD Cowen initiated its Buy rating on April 29, 2024, with a $10 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 08 ’24 when GRETHLEIN ANDREW J sold 674,348 shares for $4.56 per share. The transaction valued at 3,073,004 led to the insider holds 0 shares of the business.
Feller Faye sold 287,900 shares of GERN for $1,334,129 on Jun 10 ’24. The EVP, Chief Medical Officer now owns 0 shares after completing the transaction at $4.63 per share. On Jun 10 ’24, another insider, Kapur Anil, who serves as the EVP, Corp Strategy & CCO of the company, sold 421,875 shares for $4.64 each. As a result, the insider received 1,959,609 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 2658330368 and an Enterprise Value of 2382636544. For the stock, the TTM Price-to-Sale (P/S) ratio is 1940.40 while its Price-to-Book (P/B) ratio in mrq is 8.64. Its current Enterprise Value per Revenue stands at 1735.351 whereas that against EBITDA is -10.507.
Stock Price History:
Over the past 52 weeks, GERN has reached a high of $5.34, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is -2.65%, while the 200-Day Moving Average is calculated to be 26.10%.
Shares Statistics:
According to the various share statistics, GERN traded on average about 9.02M shares per day over the past 3-months and 9625560 shares per day over the past 10 days. A total of 602.80M shares are outstanding, with a floating share count of 552.62M. Insiders hold about 8.32% of the company’s shares, while institutions hold 69.62% stake in the company. Shares short for GERN as of 1726185600 were 71507757 with a Short Ratio of 7.93, compared to 1723680000 on 69108061. Therefore, it implies a Short% of Shares Outstanding of 71507757 and a Short% of Float of 11.93.
